NDC 11098-531-01 - INAPSINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11098-531
- Requested NDC
- 11098-531-01
- Package NDCs from labels
- 11098-531-01, 11098-531-02
- Manufacturer
- Taylor Pharmaceuticals
- Effective date
- 2007-08-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| INAPSINE - Taylor Pharmaceuticals | Taylor Pharmaceuticals | 2007-08-09 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11098-531-01 | INAPSINE | 1 mL in 1 VIAL | INJECTION | 1 | 1 | |
| 11098-531-01 | INAPSINE | 25 in 1 PACKAGE | INJECTION | 25 | 1 | |
| 11098-531-02 | INAPSINE | 25 in 1 PACKAGE | INJECTION | 25 | 1 | |
| 11098-531-02 | INAPSINE | 2 mL in 1 VIAL | INJECTION | 2 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| droperidol | ACTIVE INGREDIENT | O9U0F09D5X | INAPSINE (DROPERIDOL) INJECTION [TAYLOR PHARMACEUTICALS] | 1 | |
| droperidol | ACTIVE MOIETY | O9U0F09D5X | INAPSINE (DROPERIDOL) INJECTION [TAYLOR PHARMACEUTICALS] | 1 | |
| lactic acid | INACTIVE INGREDIENT | 33X04XA5AT | INAPSINE (DROPERIDOL) INJECTION [TAYLOR PHARMACEUTICALS] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| E516A136-46DD-AF5A-4CC5-BC93BF8CF980 | F4FA5E60-5F70-46D7-8E29-DFCF8B783F2C | 2007-08-09 | Boxed warning, Warnings, Adverse reactions | E516A136-46DD-AF5A-4CC5-BC93BF8CF980 F4FA5E60-5F70-46D7-8E29-DFCF8B783F2C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.